Table 3.
Comparison of the Primary and Secondary Outcomes Among the Groups
| Variable | Group A | Group B | Group C | Group D | P value |
|---|---|---|---|---|---|
| Intraoperative ABT rate (n,%)b | 21(16.67%) | 17(17.71%) | 12(10.34%) | 10(8.47%) | 0.104 |
| Intraoperative blood loss (mL)a | 262.70±191.72 | 250.00±178.30 | 266.38±176.28 | 267.37±221.04 | 0.914 |
| Operative time (min)a | 90.08±40.65 | 96.26±33.37 | 96.58±45.70 | 95.20±42.87 | 0.579 |
| POD 1 ABT rate (n,%)b | 11(8.73%) | 8(8.33%) | 8(6.90%) | 4(3.39%) | 0.353 |
| Intramuscular venous thrombosis (n,%)b | 22(17.40%) | 15(15.63%) | 19(16.37%) | 20(16.95%) | 0.986 |
| DVT (n,%)b | 6(4.76%) | 3(3.13%) | 3(2.58%) | 4(3.39%) | 0.820 |
| Symptomatic PE (n,%)b | 0 | 0 | 0 | 0 | - |
| Hospitalization duration (d)a | 9.14±1.44 | 8.79±1.62 | 7.38±2.78 | 7.47±2.38 | <0.001 |
| All-cause 30-day readmission (n,%)b | 4(3.17%) | 5(5.21%) | 4(3.45%) | 3(2.54%) | 0.756 |
| 30-day mortality (n,%)b | 0 | 0 | 0 | 0 | - |
Note: Intergroup comparisons were performed using analysis of variance (ANOVA), chi-square test, or Fisher’s test (aANOVA; bChi-square or Fisher’s tests).
Abbreviations: ABT, allogeneic blood transfusion; POD 1, postoperative day 1; DVT, deep venous thrombosis; PE, pulmonary embolism.